The news: Amazon’s top healthcare executive, Neil Lindsay, will step down on July 1 and be succeeded by Roy Schoenberg, MD. Schoenberg co-founded telehealth company Amwell in 2006 and launched a health AI startup last year focused on providing seniors with a personal digital companion. He will lead Amazon Health Services, which includes Amazon One Medical’s primary care and telehealth offerings as well as Amazon Pharmacy.

Why it matters: With Lindsay at the helm, Amazon significantly broadened its healthcare ambitions through its $3.9 billion acquisition of One Medical; the launch, shutdown, and subsequent overhaul of its telehealth business; and ongoing expansion of Amazon Pharmacy. At the same time, Lindsay came into the role with a consumer marketing background rather than deep healthcare expertise. This perspective likely shaped Amazon’s strategy of treating healthcare less as a traditional provider business and more as a retail category. The company has applied many of the same principles that fueled its e-commerce success to its healthcare endeavors thus far: convenience, subscription models, bundled services, price transparency, self-service, and logistics efficiency.

Schoenberg—a physician and health tech expert—could accelerate the company’s push into digital health. That may mean expanding health AI tools for patients and clinicians, strengthening partnerships with health systems and insurers, and revisiting telehealth as a B2B offering rather than a consumer service, drawing on Schoenberg's experience at Amwell.

Implications for consumer healthcare companies: Schoenberg’s traditional medical care expertise cuts both ways: It may help Amazon address long-standing healthcare challenges, or fuel renewed ambitions in a US healthcare market where insurers, drugmakers, and hospitals still control the economics.

Broadly, Big Tech has found it difficult to crack the overly complex patient-care market, seeing greater success instead with provider technology, efficiency tools, and consumer devices. Amazon specifically has struggled to make One Medical profitable (though profitability is likely secondary if it helps drive Prime engagement). It also abandoned its B2B virtual care Amazon Clinic strategy after failing to gain sufficient support from employers and health plans. A separate joint venture launched with JPMorgan Chase and Berkshire Hathaway to lower consumer healthcare costs was short-lived and unsuccessful.

As long as Amazon remains active in on-demand healthcare services and treatments, it will pose a significant competitive threat to consumer health companies (e.g., Hims & Hers, Ro, GoodRx). But the deeper Amazon ventures into disrupting a healthcare system that has proven entrenched and difficult to penetrate, the less pressure those rivals may feel compared with Amazon directly targeting their core businesses.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.